epirubicin has been researched along with Carcinoma, Small Cell in 85 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (14.12) | 18.7374 |
| 1990's | 54 (63.53) | 18.2507 |
| 2000's | 15 (17.65) | 29.6817 |
| 2010's | 4 (4.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakalos, G; Doxani, C; Miligkos, M; Mpoulimari, I; Rodopoulou, P; Zintzaras, E | 1 |
| Akahane, K; Fujii, M; Kawada, K; Murata, T; Oda, K; Ohama, T; Yatabe, Y | 1 |
| Bozonnat, MC; Chakra, M; Gervais, R; Jacot, W; Molinier, O; Pujol, JL; Quantin, X | 1 |
| Cufer, T; Kern, I; Knez, L; Ovčariček, T; Sadikov, A; Sodja, E | 1 |
| Johnson, DH | 1 |
| Aamdal, S; Aasebø, U; Boye, N; Bremnes, RM; Dahle, R; Hannisdal, E; Hatlevoll, R; Kaasa, S; Skovlund, E; Sundstrøm, S; Vigander, T; Vilsvik, J; Wang, M | 1 |
| Erturk, D; Unsal, M | 1 |
| Altinbas, M; Cetin, M; Coskun, HS; Er, O; Eser, B; Ozkan, M; Soyuer, S; Unal, A | 1 |
| Alonso, C; Arrivi, A; Artal-Cortés, A; Barneto, I; Campbell, J; Camps, C; Carrato, A; Font, A; Garcia-Giron, C; Gomez-Codina, J; Gonzalez-Larriba, JL; Isla, D; Lomas, M; Maestu, I; Meana, A; Rosell, R; Vadell, C | 1 |
| Aamdal, S; Aasebø, U; Bremnes, RM; Kaasa, S; Sundstrøm, S | 1 |
| Fantini, M; Fattori, PP; Fochessati, F; Genestreti, G; Imola, M; Ioli, G; Lazzari-Agli, L; Mianulli, AM; Papi, M; Pasquini, E; Poggi, B; Ravaioli, A; Sartori, S; Tamburini, E; Tassinari, D | 1 |
| Agostini, V; Arcangeli, V; Fantini, M; Fattori, PP; Fochessati, F; Genestreti, G; Imola, M; Ioli, G; Mianulli, AM; Oliverio, G; Papi, M; Pasquini, E; Poggi, B; Ravaioli, A; Tamburini, E; Tassinari, D | 1 |
| Brunetti, C; Carreca, I; Comella, G; Comella, P; D'Aiuto, M; D'Aniello, R; DeCataldis, G; Frasci, G; Giordano, R; Muci, D; Palmeri, S; Russo, A | 1 |
| Baldini, E; Conte, PF; Del Freo, A; Fabbri, A; Falcone, A; Innocenti, F; Pennucci, MC; Prochilo, T; Russo, F; Tibaldi, C | 1 |
| Hansen, HH; Hansen, M; Joss, RA; Renard, J; Rozencweig, M | 1 |
| Berenson, RJ; Brugger, W; Heimfeld, S; Henschler, R; Kanz, L; Mertelsmann, R | 1 |
| Brugger, W; Frommhold, H; Kanz, L; Mertelsmann, R; Pressler, K | 1 |
| Akiyama, J; Hyogo, H; Ito, K; Kida, M; Kido, S; Kojima, K; Matsuda, M; Matsuura, M; Nakajima, N; Yamamoto, K | 1 |
| Jassem, E; Jassem, J; Karnicka-Młodkowska, H; Malak, S; Moś-Antkowiak, R; Pilarska-Machowicz, A; Szymaczek-Meyer, L; Słupek, A; Wiatr, E; Zych, J | 1 |
| Cartei, G; Crivellari, D; Della Valentina, M; Foladore, S; Magri, MD; Nascimben, O; Sibau, A; Talamini, R; Trovò, MG; Veronesi, A | 1 |
| Berchier, MC; Bureau, G; Giner, V; Kroll, F; Küstner, U; Michel, J; Mommen, P; Sculier, JP; Thiriaux, J; Van Cutsem, O | 1 |
| Atikachi, B; Jiemsripong, K; Phromwas, N; Thongprasert, S | 1 |
| Jiamsriponges, K; Thongprasert, S | 1 |
| de Jonge, A; Karim, AB; Meyer, OW; Njo, KH; Slotman, BJ | 1 |
| Brancaccio, L; Comella, G; Curcio, C; D'Aprile, M; Ferrante, G; Gentile, M; Gridelli, C; Palmeri, S; Rossi, A; Veltri, E | 1 |
| Bisail, M; Farris, A; Intini, C; Sanna, G; Sarobba, MG; Scotto, T; Valzelli, S | 1 |
| Brancaccio, L; Comella, G; Curcio, C; D'Aprile, M; Gentile, M; Gridelli, C; Ianniello, GP; Maiorino, A; Palmeri, S; Pedicini, T | 1 |
| Anton, A; Gómez-Codina, J; Rosell, R; Sánchez, JJ; Vadell, C | 1 |
| Hirabayashi, M; Nagai, T; Nishikori, M; Okamura, A; Tatsumi, E; Yokoi, M | 1 |
| Chieco-Bianchi, L; Comis, S; Danova, M; Favaretto, A; Ghiotto, C; Giordano, M; Paccagnella, A; Panozzo, M; Pappagallo, G; Riccardi, A | 1 |
| Curcio, C; D'Aprile, M; Gridelli, C; Ianniello, G; Lorusso, V; Palmeri, S; Palmieri, G; Perrone, F; Rossi, A; Veltri, E | 1 |
| Berchier, MC; Bureau, G; Giner, V; Klastersky, J; Kroll, F; Küstner, U; Lecomte, J; Michel, J; Mommen, P; Paesmans, M; Sculier, JP; Sergysels, R; Van Cutsem, O | 1 |
| Charitopoulos, K; Dimitriadis, K; Economides, D; Maglaveras, N; Papagiannis, A; Vamvalis, C; Zarogoulidis, K; Ziogas, E | 1 |
| Bianco, AR; Curcio, C; D'Aprile, M; Gebbia, V; Gridelli, C; Palmeri, S; Pepe, R; Pistillucci, G; Rossi, A; Veltri, E | 1 |
| Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R; Wenger, M | 1 |
| Bardonnet-Comte, M; Berthaud, P; Chomy, F; Chomy, P; Douillard, JY; Gautier, V; Lagrange, JL; Le Chevalier, T; Milleron, B; Polin, V; Pujol, JL; Quoix, E; Rivière, A; Spaeth, D | 1 |
| Evans, TR; Gogas, H; Lofts, FJ; Mansi, JL; Millard, FJ; Wilson, R | 1 |
| Badzio, A; Jassem, J; Jereczek-Fossa, B; Karnicka-Młodkowska, H; Kowal, E; Krawczyk, K; Malak, K; Moś-Antkowaik, R; Pilarska-Machowicz, A; Radzikowska, E | 1 |
| Folga, A; Fryze, W; Jassem, E; Mincewicz, H; Olszewska, A; Słomiński, JM | 1 |
| Chen, YM; Lin, WC; Liu, JM; Perng, RP; Tsai, CM; Whang-Peng, J; Wu, HW; Wu, MF | 1 |
| Biesma, B; Cox, A; Festen, J; Postmus, PE; Splinter, TA; Tjan-Heijnen, VC; Wagener, DJ | 1 |
| Callegaro, D; Fantoni, U; Favaretto, A; Festi, G; Loy, M; Paccagnella, A; Rea, F; Sartori, F | 1 |
| Fountzilas, G; Kalofonos, C; Klouvas, G; Panoussaki, E; Pavlidis, N; Pectasides, D; Poulakis, N; Samantas, E; Skarlos, DV; Tsiakopoulos, E | 1 |
| Boher, JM; Daurès, JP; Grenier, J; Pujol, JL | 1 |
| Carmichael, J; Harris, AL; Mitchell, K; Philip, PA; Rea, D; Talbot, DC | 1 |
| Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R | 1 |
| Bosquée, L; Canon, JL; Humblet, Y; Rosier, JF; van de Velde, H; Weynants, P | 1 |
| Lohrisch, C; Murray, N; Pickles, T; Sullivan, L | 1 |
| Celik, S; Evrensel, T; Orhan, B; Samli, B; Tasdelen, I | 1 |
| Fabian, A | 1 |
| Davey, M; Davey, R; Locke, V | 1 |
| Dombernowsky, P; Hansen, HH; Hirsch, FR; Ingeberg, S; Jeppesen, N; Kristensen, C; Osterlind, K; Sorensen, PG | 1 |
| Ponarska, A; Rogala, E; Rogińska, E; Rowińska-Zakrzewska, E; Szopiński, J | 1 |
| Agelaki, S; Georgoulias, V; Kakolyris, S; Kalbakis, K; Kouroussis, C; Mavroudis, D; Palamidas, P; Raptis, A | 1 |
| Drozd-Lula, M; Jassem, J; Karnicka-Młodkowska, H; Kowal, E; Michalski, A; Moś-Antkowiak, R; Pilarska-Machowicz, A; Strug, A; Zych, J | 1 |
| Collard, P; Francis, C; Rodenstein, DO; Weynants, P | 1 |
| Abad, A; Barnadas, A; Carles, J; Haboubi, N; Jimeno, JM; Moreno, I; Ribelles, N; Rosell, R | 1 |
| Gatzemeier, U; Hossfeld, DK; Laumen, R; Lenaz, L; Neuhauss, R; Reck, M; von Pawel, J | 1 |
| Jassem, J; Kánitz, E; Kaplan, E; Kolaric, K; Mechl, Z; Pawlicki, M; Ringwald, G; Rolski, J; Schoket, Z; Vukas, D | 1 |
| Cortes-Funes, H; Evrard, D; Giaccone, G; Jassem, J; Karnicka, H; Kirkpatrick, A; Quoix, EA; Roozendaal, KJ; van Zandwijk, N; Wiatr, E | 1 |
| Nyman, CR | 1 |
| Bamberga, M; Bamberga, P; Gritti, G; Michetti, G; Ori-Belometti, M; Sarti, E; Villa, R | 1 |
| Angeletti, CA; Balbarini, A; Del Tacca, M; Macchiarini, P; Mariani, M; Mariotti, R; Mengozzi, G; Palagi, C; Petronio, AS; Squartini, F | 1 |
| Kefford, R; Raghavan, D; Rosenthal, M; Stuart-Harris, R | 1 |
| Angeletti, CA; Basolo, F; Bruno, J; Hardin, M; Macchiarini, P | 1 |
| Bonardi, G; Calciati, A; Donadio, M; Giaccone, G; Iberti, V | 1 |
| Blackstein, M; Eisenhauer, EA; Wierzbicki, R; Yoshida, S | 1 |
| Eckhardt, S; Jassem, J; Jelic, S; Kánitz, E; Kolaric, K; Koza, I; Mechl, Z; Schoket, Z; Vukas, D; Vuletic, L | 1 |
| Eich, F; Emser, W; Sybrecht, GW | 1 |
| Drings, P; Kretzschmar, A | 1 |
| Angeletti, CA; Bevilacqua, G; Danesi, R; Del Tacca, M; Fazzi, P; Giuntini, C; Macchiarini, P; Marchetti, A; Mariani, M; Mariotti, R | 1 |
| Blotta, A; Boltri, B; Busutti, L; Casadio, M; Falcone, F; Giordani, S; Lelli, G; Pannuti, F; Ramini, R | 1 |
| Banham, SW; Bicknell, S; Henderson, AF; Hughes, J; Milroy, R; Monie, RD | 1 |
| Angeletti, CA; Chella, A; Macchiarini, P; Mengozzi, G; Riva, A; Silvano, G; Solfanelli, S | 1 |
| Cole, SP; Gerlach, JH; Mirski, SE | 1 |
| Fritze, D; Harjung, H; Katz, R; Kober, B | 1 |
| Beauduin, M; Bosly, A; Delaunois, L; Duprez, P; Francis, C; Gailly, C; Humblet, Y; Machiels, J; Majois, F; Weynants, P | 1 |
| Jakobsson, M; Järvinen, M; Liippo, K; Nikkanen, TA; Nordman, E; Ojala, A; Paloheimo, S | 1 |
| Cersosimo, RJ; Hong, WK | 1 |
| Brown, JK | 1 |
| Bülzebruck, H; Drings, P; Hruska, D; Manke, HG; Schuler, G | 1 |
| Arai, R; Fukuoka, M; Furuse, K; Hayashi, S; Kawahara, M; Kiyota, M; Kodama, N; Kubota, K; Tsuruta, M; Yamamoto, M | 1 |
| Bishop, J; Brodie, G; Burns, W; Coates, A; Levi, J; Raghavan, D; Schwarz, M; Snyder, R; Tattersall, M; Thomson, D | 1 |
| Abad-Esteve, A; Fernandez, C; Monras, P; Moreno, I; Morera, J; Ribas-Mundo, M; Rosell, R; Ruiz, J | 1 |
| Canova, N; Casadio, M; Giordani, S; Giuliotti, C; Lelli, G; Martoni, A; Pannuti, F | 1 |
2 review(s) available for epirubicin and Carcinoma, Small Cell
| Article | Year |
|---|---|
Assessing the relative effectiveness and tolerability of treatments in small cell lung cancer: a network meta-analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Randomized Controlled Trials as Topic | 2013 |
Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
Topics: Bone Marrow; Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Small Cell; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Head and Neck Neoplasms; Heart; Humans; Kidney Neoplasms; Kinetics; Leukemia; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Soft Tissue Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms | 1986 |
48 trial(s) available for epirubicin and Carcinoma, Small Cell
| Article | Year |
|---|---|
Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Quality of Life; Remission Induction; Survival Rate; Vincristine | 2002 |
Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Saudi Arabia; Survival Rate; Vincristine | 2003 |
A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer.
Topics: Adult; Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Dalteparin; Disease Progression; Disease-Free Survival; Epirubicin; Female; Heparin, Low-Molecular-Weight; Humans; Lung Neoplasms; Male; Middle Aged; Time Factors; Treatment Outcome; Vincristine | 2004 |
Prospective randomized phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cranial Irradiation; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Erythrocyte Transfusion; Etoposide; Female; Hospitalization; Humans; Lung Neoplasms; Male; Middle Aged; Platelet Transfusion; Prospective Studies; Radiotherapy, Adjuvant | 2004 |
Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cross-Over Studies; Cyclophosphamide; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Health Status; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Palliative Care; Prognosis; Treatment Outcome; Vincristine | 2005 |
Weekly dose-dense cisplatin-epirubicin-paclitaxel administration with granulocyte colony-stimulating factor support does not substantially improve prognosis in extensive disease small-cell lung cancer. A SICOG phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prognosis; Survival Analysis; Treatment Outcome | 2005 |
Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Paclitaxel; Treatment Outcome | 2006 |
Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Blood Transfusion, Autologous; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasms; Predictive Value of Tests; Vincristine | 1994 |
Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Survival Analysis | 1995 |
Combination chemotherapy with cyclophosphamide, epirubicin and etoposide in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1994 |
Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vincristine | 1994 |
Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Survival Analysis | 1995 |
Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male | 1994 |
Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Digestive System Diseases; Epirubicin; Etoposide; Humans; Kidney Diseases; Life Tables; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Survival Analysis | 1994 |
Cisplatin-VP16 alternating with cyclophosphamide-epirubicin versus cyclophosphamide-epirubicin-vincristine in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Rate; Vincristine | 1993 |
Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male | 1994 |
Granulocyte-macrophage colony-stimulating factor increases dose intensity of chemotherapy in small cell lung cancer. Relationship between clinical results, peripheral blood cell modifications, and bone marrow kinetics.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cell Count; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Treatment Outcome | 1993 |
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Carmustine; Cyclophosphamide; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged | 1995 |
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Europe; Female; Humans; Ifosfamide; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Remission Induction; Survival Rate; Vindesine | 1996 |
Interferon alpha-2a and combined chemotherapy as first line treatment in SCLC patients: a randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Drug Synergism; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Remission Induction | 1996 |
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cause of Death; Dose-Response Relationship, Drug; Drug Tolerance; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Sepsis; Thrombocytopenia | 1996 |
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Cardiovascular Diseases; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pneumonectomy; Remission Induction; Survival Analysis; Transplantation Conditioning; Treatment Outcome | 1997 |
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Survival Analysis | 1997 |
Outpatient treatment with epirubicin and oral etoposide in patients with small-cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Outpatients; Survival Rate | 1997 |
Does chemotherapy-induced leukopenia predict a response in small-cell lung cancer?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Leukocyte Count; Leukopenia; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Regression Analysis; Treatment Outcome; Vincristine | 1998 |
Ifosfamide-based chemotherapy for previously treated lung cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Epirubicin; Female; Fluorouracil; Humans; Ifosfamide; Leucovorin; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Salvage Therapy | 1998 |
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cranial Irradiation; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Survival Analysis | 1999 |
A pilot study of increasing dose intensity of epirubicin and ifosfamide in patients with small cell lung cancer by using recombinant granulocyte colony-stimulating factor.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cohort Studies; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pilot Projects; Prospective Studies; Recombinant Proteins; Treatment Outcome | 1999 |
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary | 1999 |
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clini
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Nervous System Neoplasms; Neutropenia; Recurrence; Survival Rate; Thoracic Neoplasms; Thrombocytopenia; Treatment Outcome | 1999 |
[Evaluation of nervous system disorders during the course of gastric carcinoma on the basis of clinical electrophysiologic analysis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Electrophysiology; Epirubicin; Etoposide; Evoked Potentials, Auditory; Evoked Potentials, Auditory, Brain Stem; Evoked Potentials, Visual; Female; Fluorouracil; Humans; Male; Middle Aged; Nervous System Diseases; Paraneoplastic Syndromes; Stomach Neoplasms | 1999 |
Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Mesna; Middle Aged; Prospective Studies; Survival Analysis; Teniposide; Treatment Outcome; Vincristine | 2001 |
[The effect of small cell lung cancer extension on secretion of interleukin-2 (IL-2) and interferon gamma (IFM gamma) in whole blood culture stimulated with mitogens].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Etoposide; Female; Glucuronates; Humans; Ifosfamide; Interferon-gamma; Interleukin-2; Lung Neoplasms; Male; Middle Aged; Radiotherapy, Adjuvant; Remission Induction | 2001 |
A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Topotecan | 2001 |
Combination chemotherapy with vincristine, epirubicin and cyclophosphamide in small cell lung carcinoma. Polish Lung Cancer Cooperative Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Vincristine | 1992 |
Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Etoposide; Feasibility Studies; Humans; Lung Neoplasms; Male; Middle Aged; Treatment Outcome | 1992 |
Carboplatin/etoposide/vincristine therapy in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Drug Evaluation; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Recurrence; Thrombocytopenia; Time Factors; Vincristine | 1992 |
Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose 4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Survival Analysis | 1992 |
Epirubicin in previously untreated patients with small cell lung cancer: a phase II study by the EORTC Lung Cancer Cooperative Group.
Topics: Aged; Aged, 80 and over; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male | 1992 |
Cyclophosphamide, epirubicin, etoposide, cis platinum (CEVP) in combination with radiotherapy: evaluation of a protocol adopted for 6 years in 148 cases of small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1992 |
Adjuvant chemotherapy for T1-2NOMO small cell lung cancer: single-agent or combination chemotherapy?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Heart Failure; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Vomiting | 1991 |
4'-EPI-doxorubicin in advanced lung cancer. A phase II trial.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Drug Evaluation; Drugs, Investigational; Epirubicin; Female; Heart Failure; Humans; Lung Neoplasms; Male; Middle Aged | 1990 |
Epirubicin in extensive small-cell lung cancer: a phase II study in previously untreated patients: a National Cancer Institute of Canada Clinical Trials Group Study.
Topics: Carcinoma, Small Cell; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Multicenter Studies as Topic | 1990 |
Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG).
Topics: Adult; Aged; Carcinoma, Small Cell; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic | 1990 |
High dose epirubicin chemotherapy in untreated poorer prognosis small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Drug Administration Schedule; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; United Kingdom | 1990 |
Phase II feasibility study of high dose epirubicin-based regimens for untreated patients with small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction | 1990 |
Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Organoplatinum Compounds | 1989 |
A randomized study comparing platinum, doxorubicin, and VP-16 with platinum, 4'-epidoxorubicin, and VP-16 in patients with non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Podophyllotoxin; Random Allocation | 1987 |
35 other study(ies) available for epirubicin and Carcinoma, Small Cell
| Article | Year |
|---|---|
Multidisciplinary management of small cell carcinoma of the breast: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy, Modified Radical; Middle Aged; Neoadjuvant Therapy; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome; Ultrasonography, Mammary | 2014 |
Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Epirubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local | 2012 |
Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; DNA Repair; DNA-Binding Proteins; DNA, Neoplasm; Endonucleases; Epirubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Proteins; Pilot Projects; Prognosis; Retrospective Studies; Single-Blind Method; Slovenia; Topotecan; Treatment Outcome; Vincristine | 2012 |
"The guard dies, it does not surrender!" progress in the management of small-cell lung cancer?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Humans; Lung Neoplasms; Vincristine | 2002 |
Efficacy of two different platinum- or anthracycline-containing chemotherapy regimens for the treatment of small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chi-Square Distribution; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Probability; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome | 2005 |
[Chemotherapy in extended small-cell lung cancer. Retrospective analysis of two different series of patients treated with carboplatin and etoposide or ciclophosphamide-epidoxorubicin and etoposide].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies | 2005 |
Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Doxorubicin; Drug Evaluation; Epirubicin; Humans; Lung Neoplasms; Time Factors | 1984 |
[Intra-arterial infusion chemotherapy for advanced liver metastases from lung cancer via implantable vascular access: report of six cases].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin | 1995 |
Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Rate | 1993 |
Consolidative thoracic radiotherapy and prophylactic cranial irradiation in limited disease small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Lomustine; Lung Neoplasms; Methotrexate; Remission Induction; Survival Analysis; Thorax; Treatment Outcome; Vincristine | 1993 |
Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate | 1994 |
[Malignant lymphoma following operation and chemotherapy of small cell lung carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Pneumonectomy; Prednisolone; Remission Induction; Vincristine | 1993 |
[A case of binocular blindness in small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blindness; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Fatal Outcome; Humans; Lung Neoplasms; Male; Paraneoplastic Syndromes | 1998 |
Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Mesna; Prospective Studies; Recombinant Proteins; Vincristine | 1998 |
Long term results of surgery and chemotherapy in small cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Longitudinal Studies; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Postoperative Complications; Prospective Studies; Radiotherapy, Adjuvant; Survival Rate; Vincristine | 1998 |
Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Humans; Keratin-19; Keratins; Lung Neoplasms; Markov Chains; Prognosis; Proportional Hazards Models; Prospective Studies; Tissue Polypeptide Antigen | 1999 |
Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms | 1999 |
Primary neuroendocrine small cell carcinoma of the breast.
Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy, Needle; Breast Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy | 2000 |
Paclitaxel sensitization of multidrug-resistant cells to chemotherapy is independent of the cell cycle.
Topics: Amsacrine; Antineoplastic Agents; Camptothecin; Carcinoma, Small Cell; Cell Cycle; Cell Survival; Chlorambucil; Cisplatin; Daunorubicin; Drug Resistance, Multiple; Epirubicin; Genistein; Humans; Lung Neoplasms; Paclitaxel; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2001 |
Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Tomography, X-Ray Computed | 1992 |
Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy with carboplatin, etoposide and epirubicin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Epirubicin; Etoposide; Humans; Lung Neoplasms | 1992 |
[The evaluation of the cardiotoxicity of 4'-epidoxorubicin at high doses].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Echocardiography; Epirubicin; Etoposide; Female; Heart; Humans; Lung Neoplasms; Male; Middle Aged; Myocardium | 1991 |
Epirubicin: a phase II study in recurrent small-cell lung cancer.
Topics: Aged; Carcinoma, Small Cell; Drug Evaluation; Epirubicin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Remission Induction; Time Factors | 1991 |
[Nerve conduction velocity following high-dose vincristine in the treatment of small cell bronchial cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Reaction Time; Synaptic Transmission; Vincristine | 1990 |
Epirubicin weekly in combination chemotherapy with cyclophosphamide and vincristine in untreated small cell lung cancer: a phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Vincristine | 1990 |
Phase II study of high-dose epirubicin in untreated patients with small-cell lung cancer.
Topics: Aged; Carcinoma, Small Cell; Drug Evaluation; Echocardiography; Electrocardiography; Epirubicin; Female; Follow-Up Studies; Heart; Humans; Lung Neoplasms; Male; Middle Aged; Myocardium; Remission Induction; Survival Rate | 1990 |
Small cell bronchogenic carcinoma: a cyclical alternating combination of epirubicin plus cisplatin and cyclophosphamide plus etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1990 |
Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
Topics: Animals; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cell Line; Colchicine; Daunorubicin; Doxorubicin; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Epirubicin; Etoposide; Glycoproteins; Gramicidin; Humans; Immunosorbent Techniques; Isoxazoles; Lung Neoplasms; Menogaril; Mice; Mice, Inbred BALB C; Mitoxantrone; Nogalamycin; Phenotype; Vinblastine; Vincristine | 1987 |
[Results of palliative chemotherapy in advanced small cell bronchial carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Palliative Care; Prognosis; Retrospective Studies; Vincristine | 1988 |
Doxorubicin and 4'-epidoxorubicin in combination chemotherapy of extensive small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vincristine | 1988 |
Protocol cost analysis.
Topics: Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cost Control; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Epirubicin; Fees, Medical; Humans; Lung Neoplasms; Medicare; Vincristine | 1986 |
[EPICO in the treatment of small cell bronchial cancer. 3. Intermediate analysis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Vincristine | 1986 |
[A phase II study of epirubicin in advanced lung cancer].
Topics: Adenocarcinoma; Aged; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea | 1986 |
Phase I study of epirubicin given on a weekly schedule.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Small Cell; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Heart Diseases; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged | 1987 |
4'-Epidoxorubicin plus cisplatin as first-line therapy in the treatment of small cell bronchogenic carcinoma.
Topics: Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Epirubicin; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged | 1987 |